IBDEI0HL ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8202,2)
 ;;=^267165
 ;;^UTILITY(U,$J,358.3,8203,0)
 ;;=186.9^^35^482^52
 ;;^UTILITY(U,$J,358.3,8203,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8203,1,4,0)
 ;;=4^186.9
 ;;^UTILITY(U,$J,358.3,8203,1,5,0)
 ;;=5^Ca Testicular
 ;;^UTILITY(U,$J,358.3,8203,2)
 ;;=^267242
 ;;^UTILITY(U,$J,358.3,8204,0)
 ;;=198.7^^35^482^7
 ;;^UTILITY(U,$J,358.3,8204,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8204,1,4,0)
 ;;=4^198.7
 ;;^UTILITY(U,$J,358.3,8204,1,5,0)
 ;;=5^Adrenal Metastasis
 ;;^UTILITY(U,$J,358.3,8204,2)
 ;;=^267337
 ;;^UTILITY(U,$J,358.3,8205,0)
 ;;=198.5^^35^482^95
 ;;^UTILITY(U,$J,358.3,8205,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8205,1,4,0)
 ;;=4^198.5
 ;;^UTILITY(U,$J,358.3,8205,1,5,0)
 ;;=5^Mets to Bone or Bone Marrow
 ;;^UTILITY(U,$J,358.3,8205,2)
 ;;=^267336
 ;;^UTILITY(U,$J,358.3,8206,0)
 ;;=198.3^^35^482^96
 ;;^UTILITY(U,$J,358.3,8206,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8206,1,4,0)
 ;;=4^198.3
 ;;^UTILITY(U,$J,358.3,8206,1,5,0)
 ;;=5^Mets to Brain
 ;;^UTILITY(U,$J,358.3,8206,2)
 ;;=Brain Metatastasis^267334
 ;;^UTILITY(U,$J,358.3,8207,0)
 ;;=197.7^^35^482^39
 ;;^UTILITY(U,$J,358.3,8207,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8207,1,4,0)
 ;;=4^197.7
 ;;^UTILITY(U,$J,358.3,8207,1,5,0)
 ;;=5^Ca Liver, Secondary
 ;;^UTILITY(U,$J,358.3,8207,2)
 ;;=CA Liver, Secondary^267328
 ;;^UTILITY(U,$J,358.3,8208,0)
 ;;=197.0^^35^482^97
 ;;^UTILITY(U,$J,358.3,8208,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8208,1,4,0)
 ;;=4^197.0
 ;;^UTILITY(U,$J,358.3,8208,1,5,0)
 ;;=5^Mets to Lung
 ;;^UTILITY(U,$J,358.3,8208,2)
 ;;=Mets to Lung^267322
 ;;^UTILITY(U,$J,358.3,8209,0)
 ;;=196.2^^35^482^98
 ;;^UTILITY(U,$J,358.3,8209,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8209,1,4,0)
 ;;=4^196.2
 ;;^UTILITY(U,$J,358.3,8209,1,5,0)
 ;;=5^Mets to Lymph Nodes,Abdominal
 ;;^UTILITY(U,$J,358.3,8209,2)
 ;;=^267316
 ;;^UTILITY(U,$J,358.3,8210,0)
 ;;=196.3^^35^482^99
 ;;^UTILITY(U,$J,358.3,8210,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8210,1,4,0)
 ;;=4^196.3
 ;;^UTILITY(U,$J,358.3,8210,1,5,0)
 ;;=5^Mets to Lymph Nodes,Axillary Or Brachial
 ;;^UTILITY(U,$J,358.3,8210,2)
 ;;=^267317
 ;;^UTILITY(U,$J,358.3,8211,0)
 ;;=196.0^^35^482^100
 ;;^UTILITY(U,$J,358.3,8211,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8211,1,4,0)
 ;;=4^196.0
 ;;^UTILITY(U,$J,358.3,8211,1,5,0)
 ;;=5^Mets to Lymph Nodes,Cervical
 ;;^UTILITY(U,$J,358.3,8211,2)
 ;;=Lymph Nodes^267314
 ;;^UTILITY(U,$J,358.3,8212,0)
 ;;=196.1^^35^482^101
 ;;^UTILITY(U,$J,358.3,8212,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8212,1,4,0)
 ;;=4^196.1
 ;;^UTILITY(U,$J,358.3,8212,1,5,0)
 ;;=5^Mets to Lymph Nodes,Mediastinal 
 ;;^UTILITY(U,$J,358.3,8212,2)
 ;;=Lymph Nodes^267315
 ;;^UTILITY(U,$J,358.3,8213,0)
 ;;=196.8^^35^482^102
 ;;^UTILITY(U,$J,358.3,8213,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8213,1,4,0)
 ;;=4^196.8
 ;;^UTILITY(U,$J,358.3,8213,1,5,0)
 ;;=5^Mets to Lymph Nodes,Multiple Sites
 ;;^UTILITY(U,$J,358.3,8213,2)
 ;;=^267320
 ;;^UTILITY(U,$J,358.3,8214,0)
 ;;=V10.51^^35^482^56
 ;;^UTILITY(U,$J,358.3,8214,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8214,1,4,0)
 ;;=4^V10.51
 ;;^UTILITY(U,$J,358.3,8214,1,5,0)
 ;;=5^H/O Bladder Cancer
 ;;^UTILITY(U,$J,358.3,8214,2)
 ;;=^295228
 ;;^UTILITY(U,$J,358.3,8215,0)
 ;;=V10.3^^35^482^57
 ;;^UTILITY(U,$J,358.3,8215,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8215,1,4,0)
 ;;=4^V10.3
 ;;^UTILITY(U,$J,358.3,8215,1,5,0)
 ;;=5^H/O Breast Cancer
 ;;^UTILITY(U,$J,358.3,8215,2)
 ;;=^295217
 ;;^UTILITY(U,$J,358.3,8216,0)
 ;;=V10.41^^35^482^58
 ;;^UTILITY(U,$J,358.3,8216,1,0)
 ;;=^358.31IA^5^2
 ;;
 ;;$END ROU IBDEI0HL
